Tag: Coronavirus information (COVID-19)
News
DCGI nod to Serum-Oxford covid-19 vaccine for phase 2, 3 clinical trials in India
India's top drug regulator-- Drugs Controller General of India (DCGI) has granted permission to Serum Institute of India (SII) to conduct phase 2 and...
News
Serum Institute of India COVID-19 Vaccine advances to trial for phase-III on 1500 Indian patients
Serum institute has completed phase II-B3 trails and will commence phase-III trail after clearances. The third phase trail will be tested on 1500 patients...
Press Releases
GigaGen Initiates Large-Scale Manufacturing of its First-in-Class Recombinant Hyperimmune Drug for COVID-19, GIGA-2050
GigaGen Inc., a biotechnology company advancing transformative antibody drugs for infectious diseases, transplant rejection and checkpoint resistant cancers, announced the company has initiated large-scale...
News
iBio to Advance COVID-19 LicKM-Subunit Vaccine Candidate, IBIO-201
iBio, Inc., a biotech innovator and biologics contract manufacturing organization, announced that it has selected IBIO-201, its LicKM™-ubunit vaccine, as its leading candidate for...
White Papers
Hear this! Potential therapeutics for COVID-19 should be tested for auditory safety
As the COVID-19 pandemic continues to spread across the world, clinicians, academic institutions, private organizations, and governments are working tirelessly to find treatments to...
Clinical Trials
Phesi data show clinical trial suspensions continue to rise as COVID-19 impact on development persists
Analysis from Phesi shows the impact of COVID-19 on clinical development is continuing to mount, with many clinical trial sites unable to bounce back...
Press Releases
Co-Diagnostics, Inc. Enters into Agreement with Arches Research to Expand COVID-19 Testing Services
Co-Diagnostics Inc., a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced that it has entered into an...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read